Spruce Street Capital »

Research Alliance Corp Iii shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.4M 500k 10.70

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Research Alliance Corp Iii

Spruce Street Capital

View all funds holding Research Alliance Corp Iii